Transcat (NASDAQ:TRNS) Announces Earnings Results

Transcat (NASDAQ:TRNS) issued its earnings results on Tuesday. The scientific and technical instruments company reported $0.56 earnings per share for the quarter, topping the consensus estimate of $0.51 by $0.05, Zacks reports. Transcat had a return on equity of 6.15% and a net margin of 2.47%.The business had revenue of $89.33 million for the quarter, compared to analysts’ expectations of $89.79 million.

Here are the key takeaways from Transcat’s conference call:

• Transcat reported a strong fiscal fourth quarter, with consolidated revenue up 16% to $89.3 million and adjusted EBITDA up 16%, while full-year revenue rose 19% and adjusted EBITDA increased 23%.
• Service revenue continued to be the main growth engine, rising 18% in Q4 with 7% organic growth, marking the 68th consecutive quarter of year-over-year service revenue growth.
• Management said the company gained market share in calibration services during fiscal 2026 and expects sequentially higher service organic growth in Q1, with a path to high single-digit organic growth for the full year.
• Gross margins improved across the business, with consolidated gross margin up 50 basis points in Q4 and service margins expected to improve year over year in fiscal 2027 as new customer onboarding normalizes.
• Transcat emphasized an active M&A pipeline and highlighted the SCM Metrology acquisition as its first operating presence in Latin America, while also pointing to growth opportunities in key U.S. geographies and its expanding rental business.

Transcat Stock Up 5.1%

Shares of Transcat stock traded up $3.87 during trading hours on Wednesday, reaching $80.32. 438,715 shares of the company were exchanged, compared to its average volume of 144,308. The stock’s fifty day moving average is $75.75 and its 200 day moving average is $67.95. The company has a debt-to-equity ratio of 0.34, a quick ratio of 1.85 and a current ratio of 2.21. The firm has a market cap of $749.39 million, a PE ratio of 94.49 and a beta of 0.68. Transcat has a 1 year low of $50.23 and a 1 year high of $93.20.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the business. Wellington Management Group LLP boosted its holdings in Transcat by 677.7% in the fourth quarter. Wellington Management Group LLP now owns 248,539 shares of the scientific and technical instruments company’s stock valued at $14,100,000 after purchasing an additional 216,579 shares in the last quarter. Renaissance Technologies LLC increased its holdings in shares of Transcat by 109.7% in the 4th quarter. Renaissance Technologies LLC now owns 95,200 shares of the scientific and technical instruments company’s stock valued at $5,401,000 after acquiring an additional 49,800 shares during the period. ArrowMark Colorado Holdings LLC increased its stake in Transcat by 56.7% in the fourth quarter. ArrowMark Colorado Holdings LLC now owns 133,738 shares of the scientific and technical instruments company’s stock valued at $7,587,000 after purchasing an additional 48,367 shares during the period. Sei Investments Co. boosted its stake in shares of Transcat by 627.4% during the second quarter. Sei Investments Co. now owns 47,203 shares of the scientific and technical instruments company’s stock worth $4,058,000 after buying an additional 40,714 shares during the period. Finally, BNP Paribas Financial Markets increased its holdings in shares of Transcat by 352.9% in the third quarter. BNP Paribas Financial Markets now owns 41,553 shares of the scientific and technical instruments company’s stock valued at $3,042,000 after purchasing an additional 32,378 shares during the period. 98.34% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research analysts have recently weighed in on the stock. Weiss Ratings reissued a “sell (d)” rating on shares of Transcat in a research report on Monday, May 4th. Zacks Research upgraded shares of Transcat from a “strong sell” rating to a “hold” rating in a research report on Friday, May 15th. One equities research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $105.33.

Transcat Company Profile

Transcat, Inc (NASDAQ: TRNS) is a leading provider of calibration, laboratory, and metrology services in North America. Founded in 1964 and headquartered in Ronkonkoma, New York, the company specializes in ensuring the accuracy and compliance of measurement instruments across a wide range of industries. Transcat operates a network of ISO/IEC 17025–accredited laboratories and offers on-site field calibration, instrument repair, and preventive maintenance services.

In addition to its calibration services, Transcat distributes precision instrumentation and related software solutions from top manufacturers.